Report cover image

Octapharma AG - Strategic SWOT Analysis Review

Publisher GlobalData
Published Oct 06, 2025
Length 31 Pages
SKU # GBDT20455002

Description

Octapharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Octapharma AG (Octapharma) develops and manufactures human protein medicines. The company produces medicines derived from human plasma and human cell lines. Octapharma's major products focus on three therapeutic areas: haematology, immunotherapy, and critical care. It provides products for individuals with bleeding disorders, supports immune system functions, and helps restore haemostasis and blood volume in critically ill patients. The company sources plasma from company-owned plasma donation centers and other external sources. Octapharma owns plasma donation centers in the US and Germany and owns production facilities in Austria, Germany, France, Mexico, and Sweden. Its production plants carry out plasma fractionation and purification, pharmaceutical production, research and development, product labelling, packaging, storage, and distribution. Octapharma is headquartered in Lachen, Switzerland.

Octapharma AG Key Recent Developments

Aug 30,2025: BCC appoints Tim Snowball as director of communications
Jul 31,2025: University of Colorado Anschutz Medical Campus Awarded One of the Largest Clinical Trial Grants in Campus History to Lead Trauma Study

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

31 Pages
Section 1 - About the Company
Octapharma AG - Key Facts
Octapharma AG - Key Employees
Octapharma AG - Major Products and Services
Octapharma AG - History
Octapharma AG - Company Statement
Octapharma AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Octapharma AG - Business Description
R&D Overview
Octapharma AG - Corporate Strategy
Octapharma AG - SWOT Analysis
SWOT Analysis - Overview
Octapharma AG - Strengths
Octapharma AG - Weaknesses
Octapharma AG - Opportunities
Octapharma AG - Threats
Octapharma AG - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Octapharma AG, Recent Deals Summary
Section 4 – Company’s Recent Developments
Aug 30, 2025: BCC appoints Tim Snowball as director of communications
Jul 31, 2025: University of Colorado Anschutz Medical Campus Awarded One of the Largest Clinical Trial Grants in Campus History to Lead Trauma Study
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Octapharma AG, Key Facts
Octapharma AG, Key Employees
Octapharma AG, Major Products and Services
Octapharma AG, History
Octapharma AG, Other Locations
Octapharma AG, Subsidiaries
Octapharma AG, Key Competitors
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Octapharma AG, Recent Deals Summary
List of Figures
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Octapharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us